Clinical Trial Update: Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and tolerability of combining sintilimab with radiotherapy in stage IV non-small cell lung cancer. Results emphasize safety sign…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sintilimab (Tyvyt) (sintilimab)

Snippet

Sponsor: Sichuan University | Conditions: Stage IV NSCLC | Phase 1 | Status: COMPLETED | Results posted: 2025-03-04